Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Savor (SVR) / FY23

Revenue up 180.2% drove turnaround, but $92.6m cash balance drained to zero

An unprecedented revenue rebound and a working-capital release shrank losses 93.9%, but equity fell 82.8% and the company carries new debt.

Consumer / Hospitality

SVR revenue trajectory

Revenue context before the current result.

↗
Loading chart...
FY26 was $55.2m, versus $56.6m in FY25.

SVR EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
  • HY22 SVR: Outside range high ebitda margin. 12.3%; 3-period range 6.8% to 10.7%. EBITDA margin: 12.3%, above normal range; 3-period mean 8.1%, range 6.8%-10.7%.
  • FY22 SVR: Outside range low ebitda margin. 9.8%; 5-period range 10% to 14.5%. EBITDA margin: 9.8%, below normal range; 5-period mean 12.4%, range 10.0%-14.5%.
  • HY23 SVR: Outside range low ebitda margin. 6.8%; 3-period range 6.9% to 12.3%. EBITDA margin: 6.8%, below normal range; 3-period mean 10.0%, range 6.9%-12.3%.
  • FY26 SVR: Outside range high ebitda margin. 14.5%; 5-period range 9.8% to 14.2%. EBITDA margin: 14.5%, above normal range; 5-period mean 11.5%, range 9.8%-14.2%.
EBITDA margin: 14.5%, above normal range; 5-period mean 11.5%, range 9.8%-14.2%.

SVR operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
FY26 was $6.9m, versus $7.1m in FY25.

SVR working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY21 SVR: Outside range low operating working-capital movement. $-8m; 3-period range $-1m to $0.2m. Operating working-capital movement: NZ$-8.0m, below normal range; 1/3 prior periods had builds averaging NZ$0.2m, and 1 had releases averaging NZ$-1.0m.
  • FY22 SVR: Outside range high operating working-capital movement. $0.2m; 5-period range $-3.4m to $0.1m. Operating working-capital movement: NZ$0.2m, above normal range; 1/5 prior periods had builds averaging NZ$0.1m, and 4 had releases averaging NZ$-1.8m.
  • FY23 SVR: Unprecedented low operating working-capital movement. $-3.4m; 5-period range $-3.1m to $0.2m. Operating working-capital movement: NZ$-3.4m, unprecedented low; 2/5 prior periods had builds averaging NZ$0.2m, and 3 had releases averaging NZ$-1.2m.
  • HY24 SVR: Outside range high operating working-capital movement. $0.2m; 3-period range $-8m to $0m. Operating working-capital movement: NZ$0.2m, above normal range; 0/3 prior periods had builds, and 2 had releases averaging NZ$-4.5m.
Operating working-capital movement: NZ$0.2m, above normal range; 0/3 prior periods had builds, and 2 had releases averaging NZ$-4.5m.
Release date
25 May 2023
Published
23 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

FY23 vs FY22

Revenue

$52.4m

+180.2% ↑ vs $18.7m

EBITDA

$5.2m

+118.9% ↑ vs −$27.6m

Net profit after tax

−$2.3m

+94.0% ↑ vs −$38.1m

Net cash inflow from operating activities

$6.1m

+120.3% ↑ vs −$30m

Final dividend per share

−13.0c

— vs —

Profit before tax

−$2.3m

+93.9% ↑ vs −$37.7m

Cash and cash equivalents

$0m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Total assets

$56.4m

-54.0% ↓ vs $122.6m

What changed

Revenue rose 180.2% to NZ$52.4m and EBITDA flipped from NZ$-27.6m to NZ$5.2m, driving a 93.9% narrowing of the NPAT loss to NZ$-2.3m

Annolyse's historical baseline classifies this revenue growth as unprecedented (4-period mean -8.0%, range -57.8% to 18.1%), reflecting that FY23 is the first full year of the reshaped hospitality business.

The balance sheet moved in the opposite direction. Cash fell from NZ$92.6m to nil, gross borrowings of NZ$11.9m appeared on the books, total equity dropped 82.8% to NZ$17.3m, and total assets contracted 54.0% to NZ$56.4m. Operating cash flow of NZ$6.1m was assisted by a NZ$3.4m operating working-capital release, which the supplied historical pattern classifies as below the normal range (prior 3-period release averaged NZ$-1.2m).

What matters

The operating turnaround is real but small in absolute terms

  • PBT improved 93.8% to NZ$-2.3m and EBITDA reached NZ$5.2m at a 10.0% margin, in line with the company's historical positive-margin band (mean of positive periods 11.1%). The business is now near breakeven on a much larger revenue base, which means the question shifts from survival to whether margins can extend rather than whether earnings exist.
  • Cash quality depends on a working-capital release flagged as unusually favourable. OCF/EBITDA of 116.2% sits above Annolyse's historical baseline (4-period mean 70.1%). Trade debtors fell from NZ$4.9m to NZ$0.5m (debtor days from 95.9 to 3.2), reflecting hospitality's cash-on-delivery model rather than collection acceleration. The release is structural to the model shift, but its NZ$3.4m benefit will not repeat at this magnitude.
  • The balance sheet has been emptied of optionality. Cash of zero, NZ$11.9m of debt, and equity down NZ$83.2m mean net debt/EBITDA of 2.3x on a freshly minted earnings base. This matters because any earnings shortfall now translates directly into liquidity pressure rather than being absorbed by the prior NZ$92.6m cash buffer.

Expectations

No forward earnings guidance is in this release, though the commentary excerpt references January 2023 EBITDA guidance of NZ$5m+ which the result met

The supplied interim shape is heavily second-half weighted: HY23 contributed 39.5% of full-year revenue, 25.9% of full-year EBITDA, and 91.3% of the full-year NPAT loss, implying H2 ran at roughly NZ$31.7m revenue and NZ$3.9m EBITDA.

That cadence matters because it sets a high bar: if H2 reflects steady-state trading, the run-rate is approximately NZ$63m revenue and NZ$7.7m EBITDA. The release does not provide enough forward-work or pipeline disclosure to test whether this cadence holds into FY24, so the result anchors expectations without confirming them.

Quality of result

The earnings result is moderately durable

EBITDA margin of 10.0% sits within Annolyse's historical range, the effective tax rate at 0.0% does not distort the read (PBT and NPAT growth differ by only 0.1 percentage points), and the commentary references one-off restructuring and interest costs that, if normalised, would lift underlying NPAT closer to NZ$-0.6m. That suggests the operating run-rate is slightly better than reported.

Cash quality is weaker than the headline conversion ratio implies. Pre-lease free cash flow of NZ$1.8m on NPAT of NZ$-2.3m gives FCF/NPAT of -76.9% (positive cash, negative earnings), but NZ$3.4m of the OCF reflects the working-capital release flagged as below the normal historical range. Stripping that out, underlying operating cash generation is closer to NZ$2.7m, with capex at 8.2% of revenue absorbing most of it. The earnings recovery is real; the cash recovery includes a one-time tailwind from receivables compressing as the business mix shifted.

Unresolved

Open questions

What explains the NZ$92.6m cash outflow and the NZ$83.2m equity reduction during FY23, and how much was return of capital versus losses absorbed?
How much of the NZ$3.4m working-capital release is permanent due to the hospitality model versus reversible if mix changes?
Will the NZ$11.9m gross borrowings position be reduced from FY24 operating cash flow, and what are the covenant terms on this facility?
What underlying EBITDA does management expect for FY24, and does the H2 FY23 run-rate of approximately NZ$3.9m extrapolate cleanly?
Why does the release reference revenue growth of "over 70%" when the like-for-like comparison shows 180.2%, and is there a continuing-operations basis investors should anchor to?

This briefing cannot assess the venue-level economics, lease commitments, or covenant headroom that would clarify how much of FY23's near-breakeven result reflects durable hospitality margins versus a favourable first reporting year on a reshaped base.

Chat

Ask about SVR FY23

Ask follow-up questions about Savor's FY23 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about SVR FY23

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Savor's FY23 result.

What explains the NZ$92.6m cash outflow and the NZ$83.2m equity reduction during FY23, and how much was return of capital versus losses absorbed?Why does "The operating turnaround is real but small in absolute terms" matter?How strong was the cash and earnings quality in FY23?What should I watch next for SVR after FY23?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Savor Annual Report 2023

FY23 / financial report↗

Savor Annual Results - Market Announcement

FY23 / results release↗

Savor Annual Results - NZX Appendix 2

FY23 / results announcement↗

Prior comparable period

Savor 2022 annual results release timing

FY22 / financial report↗

Interim context

Savor Interim Financial Statements

HY23 / financial report↗

Savor Interim Results Announcement

HY23 / results announcement↗

Savor Interim Results Announcement

HY23 / results release↗

Release context

Savor Trading Update and Earnings Guidance Announcement - January 2023

FY23 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Revenue growth context

Revenue growth was 180.2% for this reporting period.

→

ROE and capital efficiency

ROE was -13.5%, +24.4pp versus the prior comparable period.

→

Cash conversion quality

This result converted 116.2% of EBITDA to operating cash flow, +7.9pp versus the prior comparable period.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 2.30x for this result.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when SVR publishes next

Get the next Savor briefing and related NZX reporting-season updates by email.